In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

In a nutshell Scientists discovered that an enzyme called SSAT1 turns helpful immune cells into harmful ones in psoriasis, ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...

At the recent SEC meeting for analgesics and rheumatology held on February 25, 2025, the expert panel reviewed the ...

Rhumbline Advisers lifted its holdings in shares of Zura Bio Limited (NASDAQ:ZURA – Free Report) by 37.3% during the 4th quarter, according to its most recent 13F filing with the Securities and ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

The present preclinical study elucidates the biological mechanisms of IL-17A pathway stimulation and blockade in tendinopathy. Methods We explored whether IL-17A and other IL-17 family members are ...

showed that “Atherosclerosis Signaling” and multiple IL-17-related pathways (“Role of IL-17F in Allergic Inflammatory Airway Diseases,” “Role of IL-17A in Psoriasis,” “Differential Regulation of ...